These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1430968)

  • 61. [Bacillary dysentery shigellosis].
    Matsushita S; Kawamura M
    Nihon Rinsho; 2007 Mar; 65 Suppl 3():74-7. PubMed ID: 17491367
    [No Abstract]   [Full Text] [Related]  

  • 62. The effects of health services utilization on the recovery from dysentery.
    Myaux JA; Chakraborty J; Yunus M; Khan EH; de Francisco A
    J Trop Pediatr; 1996 Feb; 42(1):38-42. PubMed ID: 8820619
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Risk factors for death in hospitalized dysentery patients in Rwanda.
    Legros D; Paquet C; Dorlencourt F; Saoult E
    Trop Med Int Health; 1999 Jun; 4(6):428-32. PubMed ID: 10444318
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group.
    Wiström J; Jertborn M; Ekwall E; Norlin K; Söderquist B; Strömberg A; Lundholm R; Hogevik H; Lagergren L; Englund G
    Ann Intern Med; 1992 Aug; 117(3):202-8. PubMed ID: 1616214
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of rhubarb (Rheum ribes L.) syrup on dysenteric diarrhea in children: a randomized, double-blind, placebo-controlled trial.
    Khiveh A; Hashempur MH; Shakiba M; Lotfi MH; Shakeri A; Kazemeini S; Mousavi Z; Jabbari M; Kamalinejad M; Emtiazy M
    J Integr Med; 2017 Sep; 15(5):365-372. PubMed ID: 28844213
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin.
    Bennish ML; Salam MA; Haider R; Barza M
    J Infect Dis; 1990 Sep; 162(3):711-6. PubMed ID: 2201742
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Empirical treatment of Shigella dysentery with trimethoprim: five-day course vs. single dose.
    Oldfield EC; Bourgeois AL; Omar AK; Pazzaglia GL
    Am J Trop Med Hyg; 1987 Nov; 37(3):616-23. PubMed ID: 3688315
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Results in the combined use of nalidixic acid with other drugs for bacillary dysentery].
    Sugano T; Tashiro F; Matsumoto T
    Nihon Densenbyo Gakkai Zasshi; 1967 Oct; 41(7):256-67. PubMed ID: 4968896
    [No Abstract]   [Full Text] [Related]  

  • 69. [Clinical study on norfloxacin in pediatrics].
    Minamitani M; Hachimori K; Kaneda K
    Jpn J Antibiot; 1990 May; 43(5):837-41. PubMed ID: 2391754
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical and laboratory studies of the photosensitizing potential of norfloxacin, a 4-quinolone broad-spectrum antibiotic.
    Ferguson J; Johnson BE
    Br J Dermatol; 1993 Mar; 128(3):285-95. PubMed ID: 8471512
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments.
    Tornaletti S; Pedrini AM
    Biochim Biophys Acta; 1988 Mar; 949(3):279-87. PubMed ID: 2831987
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and nalidixic acid.
    Ferrazzi E; Peracchi M; Biasolo MA; Faggionato O; Stefanelli S; Palù G
    Biochem Pharmacol; 1988 May; 37(9):1885-6. PubMed ID: 2837249
    [No Abstract]   [Full Text] [Related]  

  • 73. Single dose vitamin A treatment in acute shigellosis in Bangladesh children: randomised double blind controlled trial.
    Hossain S; Biswas R; Kabir I; Sarker S; Dibley M; Fuchs G; Mahalanabis D
    BMJ; 1998 Feb; 316(7129):422-6. PubMed ID: 9492664
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Absorption of ampicillin and nalidixic acid by infants and children with acute shigellosis.
    Nelson JD; Shelton S; Kusmiesz HT; Haltalin KC
    Clin Pharmacol Ther; 1972; 13(6):879-86. PubMed ID: 4673233
    [No Abstract]   [Full Text] [Related]  

  • 75. [Therapeutic use of lincomycin for bacillary dysentery].
    Fukaya K; Tani S; Tomori G
    J Antibiot B; 1965 Dec; 18(6):506-8. PubMed ID: 5296417
    [No Abstract]   [Full Text] [Related]  

  • 76. Oxolonic acid (Gramurin) in the treatment of shigella infections.
    Münnich D
    Ther Hung; 1979; 27(1):33-6. PubMed ID: 494139
    [No Abstract]   [Full Text] [Related]  

  • 77. Bacillary dysentery.
    Caldwell AD
    Br Med J; 1968 Jun; 2(5605):626-7. PubMed ID: 5658917
    [No Abstract]   [Full Text] [Related]  

  • 78. [Comparison of clinical efficacy of pipemidic acid (PPA) and kanamycin (KM) in bacillary dysentery by double blind method].
    Saito M; Tomizawa I; Konishi K; Takizawa Y; Matsubara Y; Seo T; Sagara H; Niwano K; Imagawa Y; Murata M
    Kansenshogaku Zasshi; 1983 Apr; 57(4):303-17. PubMed ID: 6413610
    [No Abstract]   [Full Text] [Related]  

  • 79. The clinical use of quinolones.
    Newsom SW
    Biochem Soc Trans; 1986 Apr; 14(2):504-7. PubMed ID: 2940135
    [No Abstract]   [Full Text] [Related]  

  • 80. Benign intracranial hypertension after nalidixic acid overdose in infants.
    Mukherjee A; Dutta P; Lahiri M; Sinha S; Mitra AK; Bhattacharya SK
    Lancet; 1990 Jun; 335(8705):1602. PubMed ID: 1972527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.